Pathology: Page 76

DrBicuspid.com announces OralDNA Labs' exclusive sponsorship of the newly created Oral Cancer & Diagnostics online community

TUCSON, AZ--(PRWEB)--DrBicuspid.com, the fastest-growing online dental news site, announced today the exclusive sponsorship of its new Oral Cancer & Diagnostics online community by OralDNA Labs, a subsidiary of Quest Diagnostics Inc., and the leaders in advancing patient wellness through salivary diagnostics.

January 9, 2011

NYU dental school continues tobacco cessation campaign

By DrBicuspid.com staff writers

The Manhattan Tobacco Cessation Program at New York University's (NYU) College of Dentistry recently released print and Internet ads urging healthcare providers to make quitting a priority with their patients who smoke.

January 9, 2011

Robotics makes oral cancer surgery less invasive

By Donna Domino

A new robotic surgical procedure offers patients with oral and head and neck cancers a less invasive treatment option that preserves speech and the ability to eat, while possibly helping them avoid radiation and chemotherapy.

January 9, 2011

Researchers ID link between alcohol, oral cancer

By DrBicuspid.com staff writers

Acetaldehyde, a flavoring compound found in many beverages and foods, appears to be a major underlying factor for the carcinogenicity of alcoholic beverages, especially for esophageal and oral cancers, according to a new study in the Journal of Experimental & Clinical Cancer Research.

January 5, 2011

Henry Schein inks distribution deal for VELscope Vx

By DrBicuspid.com staff writers

Henry Schein Dental is now the exclusive distributor of LED Dental's new VELscope Vx Enhanced Oral Assessment system in North America, the companies announced.

January 5, 2011

Head/neck cancer drug shows promise in clinical trials

By DrBicuspid.com staff writers

CEL-SCI has begun a phase III clinical trial for Multikine, its flagship immunotherapy drug for head and neck cancer. The goal is to establish Multikine as a first-line standard of care therapy in treating newly diagnosed head and neck cancer patients.

January 5, 2011

Estrogen may help precancerous cells spread in oral cavity

By DrBicuspid.com staff writers

Estrogen may increase the movement of precancerous cells in the mouth and thus promote the spread of the disease within the oral cavity, according to a new study in Cancer Prevention Research.

January 3, 2011

Head and neck cancer treatments often don't meet guidelines

By Reuters Health

NEW YORK (Reuters Health) - Care for U.S. patients with head and neck cancers deviates significantly from national guidelines, if the findings of a new study hold true.

January 2, 2011

Cigna dental program expands coverage, benefits

By DrBicuspid.com staff writers

Cigna Oral Health Integration Program now includes coverage for more conditions, including stroke, chronic kidney disease, head and neck cancer radiation, and organ transplants, the company announced.

January 2, 2011

Tumor location influences oral cancer recurrence

By DrBicuspid.com staff writers

Patients who have a recurrence of oral squamous cell carcinoma tend to do worse if the new cancer appears at the same site early or if it appears in the lymph nodes six months or longer after initial treatment, according to a study in Archives of Otolaryngology -- Head & Neck Surgery.

December 21, 2010

U.K. scientists find how HPV triggers oral cancer

By DrBicuspid.com staff writers

University of Manchester scientists have discovered for the first time an important new way in which the human papillomavirus (HPV) triggers cancer in what could lead to new treatments for cervical and oral cancer British Journal of Cancer.

December 13, 2010

Zometa aids patients with head and neck cancer

By DrBicuspid.com staff writers

The bisphosphonate Zometa appears to reduce bone loss and decrease tumor size in patients with head and neck cancer, according to a study in Cancer Research.

December 12, 2010

Previous Page

Page 76 of 87

Next Page